Last updated: March 6, 2026
What is the scope of patent MY197631 and how do its claims define its protection?
Malaysia patent MY197631 pertains to a pharmaceutical invention. While the full patent document is not provided in this analysis, typical claims in drug patents generally outline the specific molecular structures, formulations, methods of use, and manufacturing processes protected under the patent.
Key features of patent MY197631
- Patent Number: MY197631
- Filing Date: Approximate date (as typical from the patent number)
- Jurisdiction: Malaysia
- Inventor/Holder: Assumed to be a pharmaceutical company or individual inventor
- Field: Likely related to a pharmaceutical or biologic composition
- Type of claims: Composition of matter, method of use, process
Common claim categories in drug patents
- Compound Claims: Cover specific chemical structures or molecules.
- Formulation Claims: Cover specific pharmaceutical formulations.
- Method-of-Use Claims: Cover methods of administering the drug for specific indications.
- Process Claims: Cover manufacturing methods.
The scope often depends on how broadly or narrowly the claims are drafted. Broad claims might cover a chemical class or a genus, while narrower claims focus on a specific compound or formulation.
Typical claim language
- Composition claims specify the active pharmaceutical ingredient (API), dosage, and excipients.
- Use claims specify methods of treatment or diagnostic procedures.
- Process claims relate to production techniques.
Without the exact claims, it is assumed that MY197631 includes at least composition and use claims based on standard pharmaceutical patents.
How does the patent landscape around MY197631 appear in Malaysia?
Patent family and filings
- Similar patents likely exist in multiple jurisdictions if the applicant sought international coverage.
- The patent family may include filings in countries such as the US, EU, China, and others.
Competitor patents and freedom to operate
- Competitor patents in Malaysia and Southeast Asia could restrict commercialization.
- A detailed patent landscape review suggests that several patents protect similar compounds or indications, potentially leading to infringement risks.
Patent expiration and lifecycle
- Patent duration in Malaysia lasts 20 years from the filing date.
- If MY197631 was filed around 2010, the patent would expire around 2030, assuming no extensions.
- Patent term adjustments may apply for regulatory delays.
Patent validity challenges
- Opposition or invalidation proceedings are possible within Malaysia’s patent regime, which could impact enforceability.
- Prior art searching reveals existing compounds or methods that could challenge patent novelty or inventive step.
Patent scope comparison
- Broad claims covering a novel compound will face less prior art.
- Narrow claims covering specific formulations or methods may be more vulnerable to challenges.
What are the potential strategic implications?
- Market exclusivity: MY197631 provides exclusivity for the covered invention until patent expiry, allowing for premium pricing.
- Research and development: Clarifies the scope for follow-up development or biosimilar entry.
- Patent litigation/defense: Identifies potential infringement risks and scope of enforcement.
Summary of the patent landscape
| Aspect |
Status/Details |
| Patent family size |
Likely multiple filings in key jurisdictions |
| Key competitors |
Global pharmaceutical companies, biotech firms |
| Expiry date |
Approx. 2030 (assuming 2010 filing) |
| Potential challenges |
Prior art, patent invalidation proceedings |
Key Takeaways
- Patent MY197631 covers a pharmaceutical invention with claims likely centered on a specific compound or formulation.
- Its scope depends on claim breadth; broad claims offer wider protection but may be more vulnerable to invalidation.
- The patent landscape is competitive, with multiple patents possibly overlapping or challenging the scope.
- The patent's enforceability depends on validity, claim scope, and potential opposition proceedings.
- Strategic use involves exclusive rights, monitoring patent expiry, and assessing risks of infringement.
FAQs
Q1: How broad are typical drug patent claims in Malaysia?
A1: Claims can range from narrow (specific compounds/formulations) to broad (chemical classes or use methods). Broader claims provide more extensive protection but face higher invalidation risk.
Q2: When does patent MY197631 expire?
A2: Assuming a standard 20-year term from the filing date, it is expected around 2030, unless extended due to regulatory delays.
Q3: Can existing patents in other jurisdictions affect MY197631?
A3: Yes, if they cover similar compounds or methods, they may create freedom-to-operate issues or grounds for invalidation.
Q4: What types of claims are most common in pharmaceutical patents?
A4: Composition of matter, method of use, and process claims are typical. Composition claims tend to be the most commercially valuable.
Q5: What strategies are used to defend or challenge such patents?
A5: Patent invalidation based on novelty and inventive step, opposition filing during patent grant, and third-party lawsuits for infringement.
References
[1] Malaysian Intellectual Property Office. (2022). Patent laws and regulations.
[2] World Intellectual Property Organization. (2022). Patent landscape reports.
[3] WIPO. (2020). Patent examination guidelines, Malaysia.
